James Investment Research Inc. Sells 255 Shares of Concentrix Co. (NASDAQ:CNXC)

James Investment Research Inc. reduced its position in Concentrix Co. (NASDAQ:CNXCFree Report) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,699 shares of the company’s stock after selling 255 shares during the period. James Investment Research Inc.’s holdings in Concentrix were worth $290,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CNXC. Invenomic Capital Management LP lifted its holdings in shares of Concentrix by 354.3% in the 3rd quarter. Invenomic Capital Management LP now owns 472,243 shares of the company’s stock worth $24,202,000 after purchasing an additional 368,295 shares in the last quarter. Copeland Capital Management LLC lifted its holdings in shares of Concentrix by 32.9% in the 4th quarter. Copeland Capital Management LLC now owns 1,333,206 shares of the company’s stock worth $57,688,000 after purchasing an additional 329,831 shares in the last quarter. Thompson Investment Management Inc. lifted its holdings in shares of Concentrix by 1,232.8% in the 4th quarter. Thompson Investment Management Inc. now owns 140,411 shares of the company’s stock worth $6,076,000 after purchasing an additional 129,876 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Concentrix in the 3rd quarter worth $2,844,000. Finally, Geode Capital Management LLC lifted its holdings in shares of Concentrix by 5.2% in the 3rd quarter. Geode Capital Management LLC now owns 878,092 shares of the company’s stock worth $45,013,000 after purchasing an additional 43,295 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors.

Insider Activity

In other Concentrix news, Director Kathryn Hayley bought 500 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was purchased at an average cost of $50.22 per share, with a total value of $25,110.00. Following the transaction, the director now directly owns 3,034 shares in the company, valued at $152,367.48. This trade represents a 19.73 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 1,500 shares of company stock valued at $72,400 in the last ninety days. 3.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Separately, Canaccord Genuity Group cut their target price on Concentrix from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Concentrix has an average rating of “Buy” and a consensus target price of $75.00.

View Our Latest Report on Concentrix

Concentrix Trading Down 0.8 %

NASDAQ CNXC opened at $48.12 on Monday. The firm has a market capitalization of $3.10 billion, a P/E ratio of 12.97, a PEG ratio of 0.66 and a beta of 0.67. The business has a fifty day simple moving average of $46.77 and a 200 day simple moving average of $52.22. Concentrix Co. has a 12 month low of $36.28 and a 12 month high of $85.35. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 1.17.

Concentrix (NASDAQ:CNXCGet Free Report) last released its quarterly earnings results on Wednesday, January 15th. The company reported $3.26 EPS for the quarter, beating analysts’ consensus estimates of $3.01 by $0.25. The business had revenue of $2.45 billion during the quarter, compared to analyst estimates of $2.44 billion. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. Concentrix’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.36 EPS. On average, analysts predict that Concentrix Co. will post 10.11 EPS for the current fiscal year.

Concentrix Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 11th. Stockholders of record on Friday, January 31st were given a dividend of $0.3328 per share. This represents a $1.33 annualized dividend and a dividend yield of 2.77%. The ex-dividend date was Friday, January 31st. Concentrix’s dividend payout ratio is presently 35.85%.

Concentrix Profile

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Further Reading

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Co. (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.